Latest Press Releases

Meiwu Technology Co., Ltd. Announces MOU with Real BioTech (Qingdao) Ltd.

Xiamen, China, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Ltd. (hereinafter referred to as " Meiwu" or the "Company") (NASDAQ: WNW), a leading integrated platform in the beauty industry, announced that the Company signed a ...

Curium Establishes Legal Entity in China

Curium has established a legal entity in China which represents a major milestone in Curium’s international growth strategy and will enhance Curium’s ability to serve patients with cancer across Asia Curium’s local footprint will strengthen ...

Global Leaders Launch ALL IN: A High-Level Panel to Accelerate Action to End Gender-Based Violence

LONDON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Today, global leaders, survivor advocates, policymakers, and experts will gather at the Design Museum in London to launch ALL IN: Global Leaders for Ending Gender-Based Violence (GBV) ...

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company, ...

Philips Expands Commercial Availability of World’s First Real-time AI-enabled Light-based 3D Navigation Solution for Image-guided Therapy

December 1, 2025 Commercial availability expanded across Europe and the United States Real-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular procedures LumiGuide ...

Philips Launches Verida, World's First Detector-based Spectral CT Powered by Breakthrough AI, to Advance Diagnostic Precision

November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1] CE-marked, 510k pending Verida CT [2] integrates ...

Philips Unveils BlueSeal Horizon, Industry's First Helium-free 3.0T MRI Platform

November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a ...

Air Pollution Linked to More Severe Heart Disease

PR Newswire CHICAGO, Dec. 4, 2025 CHICAGO, Dec. 4, 2025 /PRNewswire/ -- Long-term exposure to common air pollutants is associated with more advanced coronary artery disease—with notable differences between women and men—according to a ...

Generic Injectables Market Dominated by Hospital Pharmacies with 61.23% Share as Online Pharmacies Surge at 18.06% CAGR Through 2030, Reports Mordor Intelligence

PR Newswire HYDERABAD, India, Dec. 4, 2025 HYDERABAD, India, Dec. 4, 2025 /PRNewswire/ -- According to a recent report by Mordor Intelligence, the generic injectables market size is valued at USD 131.68 billion in 2025 and is projected to ...

Fitterfly (a division of PB Health) Secures Patent for PGR Technology to Drive Better Diabetes Outcomes

PR Newswire MUMBAI, India, Dec. 4, 2025 In an industry first, Fitterfly by PB Health has secured a Govt. of India patent for its Personalised Glycemic Response (PGR) technology. It shows how food and activity may affect blood sugar up to ...

AI-Driven Personalized Nutrition and Wellness Solutions Market worth USD 17,867.16 MN by 2032 | Credence Research

PR Newswire LONDON, Dec. 4, 2025 LONDON, Dec. 4, 2025 /PRNewswire/ -- The global AI-Driven Personalized Nutrition and Wellness Solutions Market is entering an unprecedented phase of expansion as consumers, healthcare providers, and wellness ...

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

PR Newswire SUZHOU, China, Dec. 3, 2025 SUZHOU, China, Dec. 3, 2025 /PRNewswire/ -- On December 3, 2025 (local time in Arizona, USA), ImmVira Group ("ImmVira" or the "Company") announced a poster presentation at the 26th Annual Meeting of ...

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025

PR Newswire TOKYO and CAMBRIDGE, Mass., Dec. 3, 2025 Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer's disease by up to 8.3 years in low-amyloid group who ...

Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight

PR Newswire LAS VEGAS, Dec. 3, 2025 The dynamics of the hemophilia A market are expected to change mainly due to the increase in prevalence and the launch of upcoming therapies such as Mim8 (Novo Nordisk), DTX201 (Pebocotocogene ...

Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures

PR Newswire GALWAY, Ireland, Dec. 3, 2025 Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future. ...

LET'S CLEAR THE WATER: FLUORIDE SUPPORTS HEALTHY SMILES AND HEALTHY BRAINS

PR Newswire DELMONT, Pa., Dec. 3, 2025 PA Coalition for Oral Health offers insight on a recent fluoridation study DELMONT, Pa., Dec. 3, 2025 /PRNewswire/ -- Dental health isn't just about teeth - it's about overall well-being, learning, ...

Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®

PR Newswire INCHEON, South Korea, Dec. 1, 2025 INCHEON, South Korea, Dec. 1, 2025 /PRNewswire/ -- Celltrion, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO® (omalizumab-igec), the ...

Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates

PR Newswire OXFORD, England and CHICAGO, Dec. 2, 2025 OXFORD, England and CHICAGO, Dec. 2, 2025 /PRNewswire/ -- Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, today announced the publication ...

Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast Period (2025-2034) Due to Increasing Disease Awareness, Improved Diagnosis, and Expanding Therapeutic Options | DelveInsight

PR Newswire LAS VEGAS, Dec. 2, 2025 The narcolepsy market landscape is evolving from symptomatic management toward targeted, mechanism-based approaches that address the underlying neurochemical dysregulation of the orexin system. New drug ...

New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aß Protofibrils in CSF

PR Newswire TOKYO and CAMBRIDGE, Mass., Dec. 2, 2025 TOKYO and CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

Encompass Health Rehabilitation Hospital of Lake Worth now open in Florida

PR Newswire BIRMINGHAM, Ala. and LAKE WORTH, Fla., Dec. 2, 2025 BIRMINGHAM, Ala. and LAKE WORTH, Fla., Dec. 2, 2025 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, ...

Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium

PR Newswire DUBLIN, Dec. 2, 2025 Late-breaking HERIZON-GEA-01 presentation highlights the expanding clinical profile of Ziihera across HER2-driven gastrointestinal cancers Jazz to host investor webcast on Friday, January 9, 2026, to ...

Sun Auto Network Raises $50,000 for Susan G. Komen to Drive Progress in Breast Cancer Research

PR Newswire MESA, Ariz., Dec. 2, 2025 Sun Auto Tire & Service celebrated the expansion of its nationwide October giving campaign for Susan G. Komen, presenting a $50,000 donation to advance breast cancer research and patient programs ...

Blood Cancer United, formerly The Leukemia & Lymphoma Society, Announces New Funding for Lifesaving Cancer Breakthroughs

PR Newswire WASHINGTON, Dec. 2, 2025 With the latest funding round, Blood Cancer United's cumulative research funding tops $2 billion, continuing to help increase survival rates and improve patients' lives Blood Cancer United's new ...

Intimate Partner Violence Injury Patterns Linked with Suicidal Behavior

PR Newswire CHICAGO, Dec. 2, 2025 CHICAGO, Dec. 2, 2025 /PRNewswire/ -- Victims of intimate partner violence with suicidal behavior have characteristic injury patterns on medical imaging, according to a new study being presented today at the ...

Blood Test Shows Obesity Speeds Alzheimer's Development

PR Newswire CHICAGO, Dec. 2, 2025 CHICAGO, Dec. 2, 2025 /PRNewswire/ -- Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in ...

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

PR Newswire SHANGHAI and HONG KONG, Dec. 2, 2025 SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to ...

Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting

PR Newswire VALBY, Denmark, Dec. 2, 2025 VALBY, Denmark, Dec. 2, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that new pipeline data regarding bexicaserin (LP352), a novel investigational drug for the treatment of seizures ...

MEDINDIA

Search Medindia

Latest Press Releases

Premium Press Releases »

Press Releases »

Latest Press Releases